BioSpace News Archive

Press Releases

Axsome Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18

January 22, 2025
·
4 min read
Press Releases

OKYO Pharma Receives $1.4 Million in Non-Dilutive Funding

January 22, 2025
·
3 min read
Press Releases

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

January 22, 2025
·
9 min read
Press Releases

USANA Appoints New Chief Scientific Officer

January 22, 2025
·
3 min read
Press Releases

Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules

January 22, 2025
·
2 min read
Press Releases

Salubris Biotherapeutics Announces Positive Interim Data from the Phase 2 Trial of JK07 in Heart Failure

January 22, 2025
·
4 min read
Press Releases

IPA (ImmunoPrecise Antibodies) Pioneers AI-Designed GLP-1 Therapies: A Potential New Chapter in Diabetes Treatment

January 22, 2025
·
6 min read
Press Releases

Intellia Therapeutics Announces First Patient Dosed in the HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema

January 22, 2025
·
6 min read
Press Releases

Abbott Reports Fourth-Quarter and Full-Year 2024 Results; Issues 2025 Financial Outlook

January 22, 2025
·
28 min read
Press Releases

Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain

January 22, 2025
·
9 min read